Ditchcarbon
  • Contact
  1. Organizations
  2. Abnova (Taiwan) Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
TW
updated a month ago

Abnova (Taiwan) Corporation Sustainability Profile

Company website

Abnova Corporation, headquartered in Taiwan (TW), is a leading player in the biotechnology industry, specialising in the development and production of high-quality antibodies and related products. Founded in 2004, the company has established a strong presence in major operational regions, including North America and Europe, catering to the needs of researchers and institutions worldwide. Abnova's core offerings include a comprehensive range of monoclonal and polyclonal antibodies, recombinant proteins, and assay kits, distinguished by their exceptional specificity and reliability. The company has achieved notable milestones, such as the launch of its extensive antibody catalogue, which supports various applications in life sciences research. With a commitment to innovation and quality, Abnova has positioned itself as a trusted partner in the global biotechnology market, recognised for its contributions to advancing scientific discovery.

DitchCarbon Score

How does Abnova (Taiwan) Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Abnova (Taiwan) Corporation's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Abnova (Taiwan) Corporation's reported carbon emissions

Abnova (Taiwan) Corporation currently does not have available carbon emissions data, as indicated by the absence of specific figures for emissions in kg CO2e. Consequently, there are no reported Scope 1, Scope 2, or Scope 3 emissions totals. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. Without these commitments or data, it is unclear how Abnova plans to address its carbon footprint or contribute to climate action. As a result, Abnova's current climate strategy and emissions profile remain undefined, highlighting a potential area for future development in sustainability practices.

How Carbon Intensive is Abnova (Taiwan) Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Abnova (Taiwan) Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Abnova (Taiwan) Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Abnova (Taiwan) Corporation is in TW, which we do not have grid emissions data for.

Abnova (Taiwan) Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Abnova (Taiwan) Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Abnova (Taiwan) Corporation's Emissions with Industry Peers

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 9 days ago

QuidelOrtho

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Wuxi Apptec

CN
•
Research and development services (73)
Updated 4 days ago

OraSure Technologies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Daan Gene Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Abcam

GB
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251210.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy